These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1648886)

  • 1. Global and regional cerebral metabolic rate of 2-[18F]fluoro-2-deoxy-D-glucose in the presence of ofloxacin, a gamma-aminobutyric acid a receptor antagonist.
    Camargo EE; Sostre S; Sadzot B; Shafique I; Szabo Z; Links JM; Dannals RF; Wagner HN
    Antimicrob Agents Chemother; 1991 Apr; 35(4):648-52. PubMed ID: 1648886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral glucose metabolism and early EEG/aEEG in term newborn infants with hypoxic-ischemic encephalopathy.
    Thorngren-Jerneck K; Hellstrom-Westas L; Ryding E; Rosen I
    Pediatr Res; 2003 Dec; 54(6):854-60. PubMed ID: 12930918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
    Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
    J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral glucose metabolism measured by positron emission tomography in term newborn infants with hypoxic ischemic encephalopathy.
    Thorngren-Jerneck K; Ohlsson T; Sandell A; Erlandsson K; Strand SE; Ryding E; Svenningsen NW
    Pediatr Res; 2001 Apr; 49(4):495-501. PubMed ID: 11264432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.
    Maquet P; Dive D; Salmon E; von Frenckel R; Franck G
    Eur J Nucl Med; 1990; 16(4-6):267-73. PubMed ID: 2351175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of biological and technical factors on the variability of global and regional brain metabolism of 2-[18F]fluoro-2-deoxy-D-glucose.
    Camargo EE; Szabo Z; Links JM; Sostre S; Dannals RF; Wagner HN
    J Cereb Blood Flow Metab; 1992 Mar; 12(2):281-90. PubMed ID: 1548300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder.
    Buchsbaum MS; Wu J; Haier R; Hazlett E; Ball R; Katz M; Sokolski K; Lagunas-Solar M; Langer D
    Life Sci; 1987 Jun; 40(25):2393-400. PubMed ID: 2884547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose.
    London ED; Cascella NG; Wong DF; Phillips RL; Dannals RF; Links JM; Herning R; Grayson R; Jaffe JH; Wagner HN
    Arch Gen Psychiatry; 1990 Jun; 47(6):567-74. PubMed ID: 2350209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
    J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose.
    Blomqvist G; Stone-Elander S; Halldin C; Roland PE; Swahn CG; Haaparanta M; Solin O; Lindqvist M; Widén L
    Acta Radiol Suppl; 1991; 376():171-2. PubMed ID: 1666769
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for dissociation of insulin stimulation of blood flow and glucose uptake in human skeletal muscle: studies using [15O]H2O, [18F]fluoro-2-deoxy-D-glucose, and positron emission tomography.
    Raitakari M; Nuutila P; Ruotsalainen U; Laine H; Teräs M; Iida H; Mäkimattila S; Utriainen T; Oikonen V; Sipilä H; Haaparanta M; Solin O; Wegelius U; Knuuti J; Yki-Järvinen H
    Diabetes; 1996 Nov; 45(11):1471-7. PubMed ID: 8866549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Program for PET image alignment: effects on calculated differences in cerebral metabolic rates for glucose.
    Phillips RL; London ED; Links JM; Cascella NG
    J Nucl Med; 1990 Dec; 31(12):2052-7. PubMed ID: 2266408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional cerebral oxidative and total glucose consumption during rest and activation studied with positron emission tomography.
    Blomqvist G; Seitz RJ; Sjögren I; Halldin C; Stone-Elander S; Widén L; Solin O; Haaparanta M
    Acta Physiol Scand; 1994 May; 151(1):29-43. PubMed ID: 8048334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography.
    Rechavia E; de Silva R; Kushwaha SS; Rhodes CG; Araujo LI; Jones T; Maseri A; Yacoub MH
    J Am Coll Cardiol; 1997 Aug; 30(2):533-8. PubMed ID: 9247529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine effects on cerebral glucose metabolism.
    Cook EH; Metz J; Leventhal BL; Lebovitz M; Nathan M; Semerdjian SA; Brown T; Cooper MD
    Neuroreport; 1994 Sep; 5(14):1745-8. PubMed ID: 7827322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism.
    Spanaki MV; Siegel H; Kopylev L; Fazilat S; Dean A; Liow K; Ben-Menachem E; Gaillard WD; Theodore WH
    Neurology; 1999 Oct; 53(7):1518-22. PubMed ID: 10534261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of m-chlorophenylpiperazine on regional brain glucose utilization: a positron emission tomographic comparison of alcoholic and control subjects.
    Hommer D; Andreasen P; Rio D; Williams W; Ruttimann U; Momenan R; Zametkin A; Rawlings R; Linnoila M
    J Neurosci; 1997 Apr; 17(8):2796-806. PubMed ID: 9092601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor analysis of regional cerebral glucose metabolic rates in healthy men.
    Szabo Z; Camargo EE; Sostre S; Shafique I; Sadzot B; Links JM; Dannals RF; Wagner HN
    Eur J Nucl Med; 1992; 19(7):469-75. PubMed ID: 1644103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography in neuropsychology.
    Heiss WD; Herholz K; Pawlik G; Wagner R; Wienhard K
    Neuropsychologia; 1986; 24(1):141-9. PubMed ID: 3486378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral glucose utilization during sleep-wake cycle in man determined by positron emission tomography and [18F]2-fluoro-2-deoxy-D-glucose method.
    Maquet P; Dive D; Salmon E; Sadzot B; Franco G; Poirrier R; von Frenckell R; Franck G
    Brain Res; 1990 Apr; 513(1):136-43. PubMed ID: 2350676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.